|
gptkbp:instanceOf
|
diagnosis
|
|
gptkbp:alternativeName
|
neonatal screening
|
|
gptkbp:benefit
|
enables early treatment
prevents severe health problems
reduces infant mortality
|
|
gptkbp:countryOfOrigin
|
gptkb:United_States
|
|
gptkbp:expansion
|
1990s
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Newborn Screening
|
|
gptkbp:includesTestFor
|
gptkb:phenylketonuria
gptkb:galactosemia
sickle cell disease
cystic fibrosis
congenital hypothyroidism
congenital adrenal hyperplasia
|
|
gptkbp:introducedIn
|
1960s
|
|
gptkbp:method
|
pulse oximetry
hearing test
heel prick blood sample
|
|
gptkbp:numberOfConditionsTested
|
varies by country and state
|
|
gptkbp:performedAt
|
newborns
|
|
gptkbp:period
|
within first 24-48 hours after birth
|
|
gptkbp:purpose
|
early detection of genetic, metabolic, hormonal, and functional disorders in newborns
|
|
gptkbp:recommendation
|
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:World_Health_Organization
gptkb:American_Academy_of_Pediatrics
|
|
gptkbp:regulates
|
gptkb:state_health_departments_(US)
national health authorities
|
|
gptkbp:relatedTo
|
public health
preventive medicine
genetic counseling
|
|
gptkbp:bfsParent
|
gptkb:Tandem_Mass_Spectrometry
gptkb:March_of_Dimes
|
|
gptkbp:bfsLayer
|
6
|